What does precision oncology entail?

Click to hear more about a new partnership between Singapore’s public and private sector institutions on the adoption of personalised medicine in this CNA938 interview with A/Prof David Tan, Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore and Head, Innovation Transfer Office (Research Office) at the National University Health System.

More information about this partnership